These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29761876)
1. Differential GIP/GLP-1 intestinal cell distribution in diabetics' yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length. Palha AM; Pereira SS; Costa MM; Morais T; Maia AF; Guimarães M; Nora M; Monteiro MP J Cell Biochem; 2018 Sep; 119(9):7506-7514. PubMed ID: 29761876 [TBL] [Abstract][Full Text] [Related]
2. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal. Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746 [TBL] [Abstract][Full Text] [Related]
3. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884 [TBL] [Abstract][Full Text] [Related]
4. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels. Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256 [TBL] [Abstract][Full Text] [Related]
5. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects. Rohde U Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040 [TBL] [Abstract][Full Text] [Related]
6. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass. Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297 [TBL] [Abstract][Full Text] [Related]
7. Customization of biliopancreatic limb length to modulate and sustain antidiabetic effect of gastric bypass surgery. Pal A; Rhoads DB; Tavakkoli A Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G287-G299. PubMed ID: 29097359 [TBL] [Abstract][Full Text] [Related]
8. A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity. Murad AJ; Cohen RV; de Godoy EP; Scheibe CL; Campelo GP; Ramos AC; de Lima RC; Pinto LEV; Coelho D; Costa HBF; Pinto ÍMP; Pereira T; Teófilo FRS; Valadão JA Obes Surg; 2018 Mar; 28(3):599-605. PubMed ID: 28933045 [TBL] [Abstract][Full Text] [Related]
9. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748 [TBL] [Abstract][Full Text] [Related]
10. The entero-insular axis: implications for human metabolism. Ranganath LR Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966 [TBL] [Abstract][Full Text] [Related]
11. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780 [TBL] [Abstract][Full Text] [Related]
12. Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery. Pal A; Rhoads DB; Tavakkoli A Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G668-G678. PubMed ID: 30896970 [TBL] [Abstract][Full Text] [Related]
13. Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. Cavin JB; Couvelard A; Lebtahi R; Ducroc R; Arapis K; Voitellier E; Cluzeaud F; Gillard L; Hourseau M; Mikail N; Ribeiro-Parenti L; Kapel N; Marmuse JP; Bado A; Le Gall M Gastroenterology; 2016 Feb; 150(2):454-64.e9. PubMed ID: 26481855 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study. Miras AD; Kamocka A; Pérez-Pevida B; Purkayastha S; Moorthy K; Patel A; Chahal H; Frost G; Bassett P; Castagnetto-Gissey L; Coppin L; Jackson N; Umpleby AM; Bloom SR; Tan T; Ahmed AR; Rubino F Diabetes Care; 2021 May; 44(5):1082-1090. PubMed ID: 33158945 [TBL] [Abstract][Full Text] [Related]
15. A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass. Hernández-Montoliu L; Rodríguez-Peña MM; Puig R; Astiarraga B; Guerrero-Pérez F; Virgili N; López-Urdiales R; Osorio J; Monseny R; Lazzara C; Sobrino L; Pérez-Maraver M; Pérez-Prieto M; Pellitero S; Fernández-Veledo S; Vendrell J; Vilarrasa N Front Endocrinol (Lausanne); 2023; 14():1181744. PubMed ID: 37916149 [TBL] [Abstract][Full Text] [Related]
16. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Laferrère B; Heshka S; Wang K; Khan Y; McGinty J; Teixeira J; Hart AB; Olivan B Diabetes Care; 2007 Jul; 30(7):1709-16. PubMed ID: 17416796 [TBL] [Abstract][Full Text] [Related]